Infant Formula Fat Composition to Reduce Calcium Soap Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Infant formula compositions differ significantly from human milk in fat composition, leading to higher excretion of insoluble calcium and magnesium soaps, causing constipation and gut discomfort in infants.
Innovation Solution
A fat composition comprising a mixture of bovine milk fat and vegetable lipid sources, characterized by specific distributions and ratios of fatty acids at the sn-1,3 positions, reduces soap formation and enhances calcium absorption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If infant formula uses vegetable and/or bovine milk lipid sources with palmitic acid esterified at sn-1 and/or sn-3 positions, then the fat composition resembles conventional infant formula, but more free palmitic acid is released during digestion leading to increased formation of insoluble calcium and magnesium soaps in the intestine
Solution Approach 1:
The patent applies local quality by specifically controlling the position of palmitic acid esterification on the glycerol backbone. Instead of uniform distribution, palmitic acid is predominantly esterified at the sn-2 position while other fatty acids occupy sn-1 and sn-3 positions. This localized arrangement ensures that during digestion, less free palmitic acid is released to form insoluble soaps, directly resolving the contradiction between maintaining conventional fat composition and reducing harmful soap formation.
Solution Approach 2:
The patent changes the critical parameter of fatty acid distribution at specific glycerol positions. By modifying the esterification pattern from random or sn-1/3 predominant to sn-2 predominant for palmitic acid, the patent alters the digestion behavior and reduces soap formation. This parameter change transforms the fat composition to achieve both conventional-like overall composition and reduced harmful effects.
2Loss of energy
If more calcium soaps are excreted, then fat absorption may be maintained, but less calcium is absorbed in the intestines reducing availability for bone mineralization
Solution Approach 1:
The patent converts the potentially harmful effect of palmitic acid soap formation into a benefit by controlling its magnitude. By ensuring predominant sn-2 esterification of palmitic acid, the patent reduces free palmitic acid release and consequently reduces harmful soap formation. This allows sufficient calcium absorption for bone mineralization while maintaining adequate fat absorption, transforming the trade-off into a winning scenario for both nutrients.
3Ease of manufacture
If infant formula fat composition differs from human milk, then production and storage become easier, but gut discomfort and constipation increase due to harder stools
Solution Approach 1:
The patent applies local quality by specifically controlling the position of palmitic acid esterification on the glycerol backbone. Instead of uniform distribution, palmitic acid is predominantly esterified at the sn-2 position while other fatty acids occupy sn-1 and sn-3 positions. This localized arrangement ensures that during digestion, less free palmitic acid is released to form insoluble soaps, directly resolving the contradiction between maintaining conventional fat composition and reducing harmful soap formation.
Solution Approach 2:
The patent changes the critical parameter of fatty acid distribution at specific glycerol positions. By modifying the esterification pattern from random or sn-1/3 predominant to sn-2 predominant for palmitic acid, the patent alters the digestion behavior and reduces soap formation. This parameter change transforms the fat composition to achieve both conventional-like overall composition and reduced harmful effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition results in softer stools, reduced constipation, and improved calcium and fat absorption, addressing nutritional inefficiencies in infant formula.
Implementation Method 1
less insoluble calcium and magnesium palmitic acid soaps are formed in the intestine
Implementation Method 2
less calcium is absorbed in the intestines and hence less calcium from the nutritional composition is available for bone mineralization
Implementation Method 3
less fat absorption and hence less caloric intake which could in some cases lead to nourishing problems
Data Source
AI summary
The invention relates to a fat composition and a nutritional composition comprising such fat composition. The nutritional composition is particularly suitable for therapeutic applications in treating gut discomfort and/or constipation as well as in non-therapeutic applications for reducing the intestinal formation of calcium and magnesium fatty acid soaps. The fat composition comprises a mixture of triacylglycerols (TAG) originating from a bovine milk fat source and a vegetable lipid source, said mixture being characterized by: (a) a content of butanoate groups (C4:0) of 0.5-2.8% by weight based on total weight of fatty acid acyl groups in TAG; (b) a wLCSFA(sn-1,3) of 18.0-35.0% by weight; (c) a mLCFA (sn-1,3) of 48.0-61.0 mol %; and (d) a ratio mLCFA (sn-1,3)/SFA of 0.70-1.25, wherein: —LCFA(sn-1,3) are the long chain fatty acid acyl groups having a chain length of 12 or more carbon atoms at the sn-1 and sn-3 position in TAG; —LCSFA(sn-1,3) are the long chain saturated fatty acid acyl groups having a chain length of 12 or more carbon atoms at the sn-1 and sn-3 position in TAG; —wLCSFA(sn-1,3) is the amount of LCFA(sn-1,3) in % by weight based on total weight of fatty acid acyl groups in TAG; —mLCFA(sn-1,3) is the mole fraction of LCFA(sn-1,3) based on total moles of fatty acid acyl groups in the TAG as expressed in mol %; and—SFA is the mole fraction of saturated fatty acid acyl groups in the TAG as expressed in mol %.